About HEC
Total assets
Listed Companies
Existing staff
Laboratory
+
R & D team
+
Patents
More than 3,500 patents have been applied, including more than 1,500 foreign patents
HEC Group has made accumulative donations worth over 200 million yuan to the field of social welfare and charity
-
New Electronic Materials
-
Biomedicine Industry
-
Health And Wellness
New Electronic Materials
New electronic materials - The new electronic material industry already owns an A-share listed company HEC (600673.SH); it develops core industries around the capacitor industry chain and battery material industry clusters, and has created four major industry clusters: electronic component, high-end aluminum foil, new chemical material, and new energy material. Relying on the complete industry chain and technological innovation advantages, it actively responds to the national "double carbon" policy, closely focuses on market demand, continuously improves the industrial layout, and strives to build an internationally advanced new energy material platform company within 5-8 years!
Learn mode →
Biomedicine Industry
Biomedicine industry- The biomedical industry mainly includes Sunshine Lake Pharma Co., Ltd. and HEC Pharm Co., Ltd. two business systems. Sunshine Lake Pharma Co., Ltd. includes HEC Pharmaceutical Research Institute, domestic preparation business ("HEC Changjiang Pharmaceutical", which has been listed in Hong Kong stock market) and pharmaceutical business for foreign markets; HEC Pharm Co., Ltd. is mainly engaged in bio-fermentation API.
Learn mode →
Health And Wellness
Health and wellness - HEC Health has a research institute with more than 200 high-end R&D talents, and has built an industrialization base mainly in Yichang, Hubei, supplemented by Shaoguan, Guangdong and Nyingchi, Tibet. In the future, the research and development and production base of Cordyceps sinensis deep processing products will be built in Zhuhai Hengqin and Dongyang, Zhejiang. Adhering to the concepts of safety, health, ecology and high technology, HEC will build a large-scale health industry dominated by Cordyceps sinensis, and continue to develop and innovate ecologically bred Cordyceps sinensis and its deep-processed products, health food, health care products, cosmetics and other large-scale health products cluster.
Learn mode →
R & D Center
In 2005, HEC established the General Research Institute, which consists of three branches: the Pharmaceutical Research Institute, the Great Health Research Institute and the New Energy Research Institute. Through 17 years of unremitting efforts, it has possessed continuous and systematic research and development capabilities. The research and development concept is occidentalized, the scientific research talents are globalized, and the research and development and testing equipment are first-class.
The institute has more than 20 foreign and returnee experts, more than 100 doctors, more than 1,000 masters, more than 1,700 R&D personnel, and has first-class medicinal chemistry capabilities, thus forming a unique R&D model of "domestic elite-led, returnee expert guidance, overseas consultant guidance”.
The institute has applied for more than 3,500 patents, and its foreign patents are more than 1,500; the total number of pharmaceutical patents, compound patents, compound PCT patents, patent application growth rate and patent quality applied by HEC drugs each year rank in the forefront of China.
HEC Trends
2024-08-01
TOP20! HEC Technology was listed in the 2024 Hurun China Top 100 New Materials Companies list
2024-07-27
2024-04-12
WeChat public account
2022 Copyright by HEC Group 粵ICP備19034764號-1